Robbins LLP logo white Background.png
CS Disco, Inc. Shareholders: Contact Robbins LLP for Information About the Firm's Investigation of LAW's Officers and Directors
October 24, 2023 06:17 ET | Robbins LLP
CS Disco, Inc. (LAW) CEO Abruptly Left Company Following Complaints of Alleged Groping and Other Misconduct
Robbins LLP logo white Background.png
CS Disco, Inc. (LAW) Stock News: Investors with Losses Should Contact Robbins LLP About Their Options Regarding the Class Action Lawsuit
October 23, 2023 13:25 ET | Robbins LLP
CS Disco (LAW) Misled Investors Regarding its Business Prospects
EQUASENS : Résultats
EQUASENS : Résultats Semestriels 2023
September 29, 2023 12:00 ET | EQUASENS
Villers-lès-Nancy, le 29 septembre 2023 - 18h00 (CET) COMMUNIQUE DE PRESSE Résultats Semestriels 2023 Croissance portée par une conjoncture favorable : Chiffre d’affaires : +8,7% à 112,6 M€...
EQUASENS_EN.png
EQUASENS: H1 2023 Results
September 29, 2023 12:00 ET | EQUASENS
Villers-lès-Nancy, 29 September 2023 - 6:00 p.m. (CET) PRESS RELEASE H1 2023 Results Growth momentum bolstered by favourable market conditions: Revenue: €112.6m, +8.7% Current Operating Income:...
Inventiva et Hepalys
Inventiva et Hepalys Pharma, Inc., signent un accord de licence exclusif pour développer et commercialiser lanifibranor au Japon et en Corée du Sud
September 20, 2023 16:00 ET | INVENTIVA
Hepalys Pharma, Inc. est une nouvelle société créée par Catalys Pacific, et dans laquelle Inventiva détient une participation de 30%. Dans le cadre de l’accord de licence exclusif, Inventiva...
Inventiva and Hepaly
Inventiva and Hepalys Pharma, Inc. announce exclusive licensing agreement to develop and commercialize lanifibranor in Japan and South Korea
September 20, 2023 16:00 ET | INVENTIVA
Hepalys Pharma, Inc. is a new company created by Catalys Pacific and in which Inventiva has a 30% ownership position.  Under the exclusive licensing agreement, Inventiva will receive a $10 million...
EGIDE : Succès de l’
EGIDE : Succès de l’augmentation de capital
September 05, 2023 11:30 ET | EGIDE
Communiqué de presse Bollène, 5 septembre 2023– 17h30 (CET) Succès de l’augmentation de capitald’un montant brut de 1,9 million d’euros Demandes de souscription portant sur 6 430 112 actions...
Egide: Success of th
Egide: Success of the Capital Increase
September 05, 2023 11:30 ET | EGIDE
Press release Bollène, 5 September 2023 – 7:30 (CET) A successful capital increase with gross proceeds of 1.9 million euros Subscription applications received for 6,430,112 new shares, i.e. a...
ctm
Castellum, Inc. Announces Strong Second Quarter Financial Results
August 14, 2023 06:45 ET | Castellum, Inc.
BETHESDA, Md., Aug. 14, 2023 (GLOBE NEWSWIRE) -- Castellum, Inc. (NYSE-American: CTM) (the “Company”), a cybersecurity and electronic warfare company focused on the federal government, announces...
Egide:  Issuing of a
Egide: Issuing of a capital increase / American subsidiaries no longer up for sale.
August 14, 2023 02:14 ET | EGIDE
Press release Bollène, 14 August 2023 – 8:00 (CET) The publication or distribution of this press release in certain countries may be prohibited in accordance with legislation. The information...